Aspirin, myocardial infarction, and gastrointestinal bleeding.
J G
JG
Cleland
F
F
Alamgir
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects / Q000627:therapeutic use; D001241:Aspirin / Q000009:adverse effects / Q000627:therapeutic use*; D004415:Dyspepsia / Q000139:chemically induced; D006471:Gastrointestinal Hemorrhage / Q000139:chemically induced*; D006801:Humans; D009203:Myocardial Infarction / Q000517:prevention & control*; D010919:Placebos; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D015996:Survival Rate; D013927:Thrombosis / Q000517:prevention & control
D000894:Anti-Inflammatory Agents, Non-Steroidal; D010919:Placebos; D010975:Platelet Aggregation Inhibitors; D001241:Aspirin